Glucagonoma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
Other imaging studies for glucagonoma include | Other imaging studies for glucagonoma include positron emission tomography scan and somatostation receptor scintigraphy. | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
=== | ===Positron Emission Tomography=== | ||
*Positron emission tomography (PET) scan: When doing this test, a small amount of a radioactive medium is injected into your body and absorbed by the organs or tissues. This radioactive substance gives off energy which in turn is used to produce the images. | *Positron emission tomography (PET) scan: When doing this test, a small amount of a radioactive medium is injected into your body and absorbed by the organs or tissues. This radioactive substance gives off energy which in turn is used to produce the images. Positron emission tomography can provide more helpful information than either CT or MRI scans. It is useful to see if the cancer has spread to the [[lymph nodes]] and it is also useful for your doctor to locate where the cancer has spread. | ||
===Somatostatin Receptor Scintigraphy=== | ===Somatostatin Receptor Scintigraphy=== | ||
<gallery> | <gallery> | ||
Revision as of 13:32, 15 October 2015
|
Glucagonoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Glucagonoma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Glucagonoma other imaging findings |
|
Risk calculators and risk factors for Glucagonoma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Other imaging studies for glucagonoma include positron emission tomography scan and somatostation receptor scintigraphy.
Other Imaging Findings
Positron Emission Tomography
- Positron emission tomography (PET) scan: When doing this test, a small amount of a radioactive medium is injected into your body and absorbed by the organs or tissues. This radioactive substance gives off energy which in turn is used to produce the images. Positron emission tomography can provide more helpful information than either CT or MRI scans. It is useful to see if the cancer has spread to the lymph nodes and it is also useful for your doctor to locate where the cancer has spread.
Somatostatin Receptor Scintigraphy
-
![Somatostatin receptor scintigraphy with SPECT acquisition. Area of increased uptake anterior to the left kidney and medial to the spleen, consistent with the pancreatic mass[1]](/images/3/3c/Scintigraphy.jpg)
Somatostatin receptor scintigraphy with SPECT acquisition. Area of increased uptake anterior to the left kidney and medial to the spleen, consistent with the pancreatic mass[1]
![Somatostatin receptor scintigraphy with SPECT acquisition. Area of increased uptake anterior to the left kidney and medial to the spleen, consistent with the pancreatic mass[1]](/index.php/File:Scintigraphy.jpg)
References
- ↑ Erdas E, Aste N, Pilloni L, Nicolosi A, Licheri S, Cappai A; et al. (2012). "Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association?". BMC Cancer. 12: 614. doi:10.1186/1471-2407-12-614. PMC 3543729. PMID 23259638.